Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
Olay
T
T
Instituto di Farmacologia Española Méndez Alvaro, 57 28045 Madrid, Spain.
Vicente
M V
MV
Rodríguez
A
A
D000818:Animals; D004195:Disease Models, Animal; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D005578:Fosfomycin / Q000627:therapeutic use*; D005839:Gentamicins / Q000627:therapeutic use*; D006801:Humans; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D011817:Rabbits; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects*; D014640:Vancomycin / Q000627:therapeutic use*
D005839:Gentamicins; D005578:Fosfomycin; D014640:Vancomycin